Topical Dermatology Program

CombinatoRx has two product candidates, CRx-191 and CRx-197 that have advanced into clinical trials for the topical treatment of inflammatory dermatoses, specifically targeting psoriasis and atopic dermatitis.

Our platform lends itself well to finding novel synergies that can be turned into topical co-formulations. These can be quickly moved into proof-of-concept clinical trials, potentially representing truly innovative products for the topical dermatology market.